These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16597674)

  • 1. Cellular and molecular mechanisms of tissue protection by lipophilic calcium channel blockers.
    Menne J; Park JK; Agrawal R; Lindschau C; Kielstein JT; Kirsch T; Marx A; Muller D; Bahlmann FH; Meier M; Bode-Böger SM; Haller H; Fliser D
    FASEB J; 2006 May; 20(7):994-6. PubMed ID: 16597674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol induces mitochondrial biogenesis and ameliorates Ang II-induced cardiac remodeling in transgenic rats harboring human renin and angiotensinogen genes.
    Biala A; Tauriainen E; Siltanen A; Shi J; Merasto S; Louhelainen M; Martonen E; Finckenberg P; Muller DN; Mervaala E
    Blood Press; 2010 Jun; 19(3):196-205. PubMed ID: 20429690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement activation in angiotensin II-induced organ damage.
    Shagdarsuren E; Wellner M; Braesen JH; Park JK; Fiebeler A; Henke N; Dechend R; Gratze P; Luft FC; Muller DN
    Circ Res; 2005 Sep; 97(7):716-24. PubMed ID: 16109917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?
    Burnier M; Pruijm M; Wuerzner G
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):981-7. PubMed ID: 19619074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects.
    Park JK; Müller DN; Mervaala EM; Dechend R; Fiebeler A; Schmidt F; Bieringer M; Schäfer O; Lindschau C; Schneider W; Ganten D; Luft FC; Haller H
    Kidney Int; 2000 Oct; 58(4):1420-30. PubMed ID: 11012877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage.
    Fiebeler A; Nussberger J; Shagdarsuren E; Rong S; Hilfenhaus G; Al-Saadi N; Dechend R; Wellner M; Meiners S; Maser-Gluth C; Jeng AY; Webb RL; Luft FC; Muller DN
    Circulation; 2005 Jun; 111(23):3087-94. PubMed ID: 15939810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducible NOS inhibition, eicosapentaenoic acid supplementation, and angiotensin II-induced renal damage.
    Theuer J; Shagdarsuren E; Muller DN; Kaergel E; Honeck H; Park JK; Fiebeler A; Dechend R; Haller H; Luft FC; Schunck WH
    Kidney Int; 2005 Jan; 67(1):248-58. PubMed ID: 15610248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the fixed-dose combination lercanidipine-enalapril in renal protection.
    Egan CG; Pontremoli R
    J Nephrol; 2011; 24(4):428-37. PubMed ID: 21279953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II-induced sudden arrhythmic death and electrical remodeling.
    Fischer R; Dechend R; Gapelyuk A; Shagdarsuren E; Gruner K; Gruner A; Gratze P; Qadri F; Wellner M; Fiebeler A; Dietz R; Luft FC; Muller DN; Schirdewan A
    Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1242-53. PubMed ID: 17416596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genes.
    Mervaala E; Müller DN; Park JK; Dechend R; Schmidt F; Fiebeler A; Bieringer M; Breu V; Ganten D; Haller H; Luft FC
    Hypertension; 2000 Jan; 35(1 Pt 2):360-6. PubMed ID: 10642325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of bosentan on NF-kappaB, inflammation, and tissue factor in angiotensin II-induced end-organ damage.
    Muller DN; Mervaala EM; Schmidt F; Park JK; Dechend R; Genersch E; Breu V; Löffler BM; Ganten D; Schneider W; Haller H; Luft FC
    Hypertension; 2000 Aug; 36(2):282-90. PubMed ID: 10948091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosuvastatin protects against angiotensin II-induced renal injury in a dose-dependent fashion.
    Park JK; Mervaala EM; Muller DN; Menne J; Fiebeler A; Luft FC; Haller H
    J Hypertens; 2009 Mar; 27(3):599-605. PubMed ID: 19262227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension, possible vascular protection and lercanidipine.
    Ram CV
    Expert Rev Cardiovasc Ther; 2006 Nov; 4(6):783-8. PubMed ID: 17173495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of lercanidipine on kidney microanatomy in Cohen-Rosenthal diabetic hypertensive rats.
    Rosenthal T; Rosenmann E; Tomassoni D; Amenta F
    J Cardiovasc Pharmacol Ther; 2007 Jun; 12(2):145-52. PubMed ID: 17562785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephroprotective effect of treatment with calcium channel blockers in spontaneously hypertensive rats.
    Sabbatini M; Vitaioli L; Baldoni E; Amenta F
    J Pharmacol Exp Ther; 2000 Sep; 294(3):948-54. PubMed ID: 10945845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats.
    Martinez ML; Castro MM; Rizzi E; Fernandes K; Demacq C; Bendhack LM; Gerlach RF; Tanus-Santos JE
    Eur J Pharmacol; 2008 Sep; 591(1-3):224-30. PubMed ID: 18634778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lercanidipine, a third generation calcium antagonist. Which advantages?].
    Meier P; Burnier M
    Rev Med Suisse; 2006 Sep; 2(78):2047-50, 2052-3. PubMed ID: 17019840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II induced inflammation in the kidney and in the heart of double transgenic rats.
    Theuer J; Dechend R; Muller DN; Park JK; Fiebeler A; Barta P; Ganten D; Haller H; Dietz R; Luft FC
    BMC Cardiovasc Disord; 2002; 2():3. PubMed ID: 11835691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats.
    Toba H; Yoshida M; Tojo C; Nakano A; Oshima Y; Kojima Y; Noda K; Wang J; Kobara M; Nakata T
    Hypertens Res; 2011 Apr; 34(4):521-9. PubMed ID: 21270815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.